APOC1 and hepatocellular carcinoma: For instance, inhibition of APOC1 can increase the M1/M2 macrophage ratio through regulating ferroptosis and improve the anti-PD-1 immunotherapy efficacy for hepatocellular carcinoma (HCC) (29).